Relay Therapeutics Stock Quote RLAY - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.305

Bid

3.30

Ask

3.31

Volume

357,742

3.24 Day's Range 3.40

1.775 52 Week Range 10.72

Market Cap

566.626M

Previous Close

3.45

Open

3.30

Last Trade

100

3.305

Last Trade Time

10:19:54

Financial Volume

$ 1,192,234

VWAP

3.3327

Average Volume (3m)

2,346,638

Shares Outstanding

171,444,966

Dividend Yield

PE Ratio

-1.75

Earnings Per Share (EPS)

-1.97

Revenue

23.21M

Net Profit

-337.71M

Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, i... Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.relaytx.com

Headquarters

Wilmington, Delaware, USA

Founded

Relay Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RLAY. The last closing price for Relay Therapeutics was $3.45. Over the last year, Relay Therapeutics shares have traded in a share price range of $ 1.775 to $ 10.72.

Relay Therapeutics currently has 171,444,966 shares outstanding. The market capitalization of Relay Therapeutics is $591.49 million. Relay Therapeutics has a price to earnings ratio (PE ratio) of -1.75.

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025

Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.005	0.151515151515	3.3	3.64	3.2	1369873	3.40244522	CS
4	0.505	18.0357142857	2.8	3.64	2.75	1391121	3.10953563	CS
12	0.135	4.25867507886	3.17	3.64	1.775	2346638	2.83897683	CS
26	-1.495	-31.1458333333	4.8	5.99	1.775	2307846	3.46379394	CS
52	-4.545	-57.898089172	7.85	10.72	1.775	2083178	4.98437909	CS
156	-10.295	-75.6985294118	13.6	33.06	1.775	1519693	9.77676534	CS
260	-30.675	-90.2736904061	33.98	64.37	1.775	1166211	14.53127761	CS

RLAY - Frequently Asked Questions (FAQ)

What is the current Relay Therapeutics share price?

The current share price of Relay Therapeutics is $ 3.305

How many Relay Therapeutics shares are in issue?

Relay Therapeutics has 171,444,966 shares in issue

What is the market cap of Relay Therapeutics?

The market capitalisation of Relay Therapeutics is USD 591.49M

What is the 1 year trading range for Relay Therapeutics share price?

Relay Therapeutics has traded in the range of $ 1.775 to $ 10.72 during the past year

What is the PE ratio of Relay Therapeutics?

The price to earnings ratio of Relay Therapeutics is -1.75

What is the cash to sales ratio of Relay Therapeutics?

The cash to sales ratio of Relay Therapeutics is 25.48

What is the reporting currency for Relay Therapeutics?

Relay Therapeutics reports financial results in USD

What is the latest annual turnover for Relay Therapeutics?

The latest annual turnover of Relay Therapeutics is USD 23.21M

What is the latest annual profit for Relay Therapeutics?

The latest annual profit of Relay Therapeutics is USD -337.71M

What is the registered address of Relay Therapeutics?

The registered address for Relay Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Relay Therapeutics website address?

The website address for Relay Therapeutics is www.relaytx.com

Which industry sector does Relay Therapeutics operate in?

Relay Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Symbol	Price	Vol.
RBNERobin Energy Ltd	$ 15.44 (360.90%)	48.09M
LGHLWLion Group Holding Ltd	$ 0.0067 (179.17%)	3.42M
USEGUS Energy Corp	$ 2.50 (76.06%)	67.01M
CGBSCrown LNG Holdings Ltd	$ 0.138 (64.29%)	524.79M
ICONIcon Energy Corporation	$ 2.87 (60.34%)	45.38M
SBETSharpLink Gaming Inc	$ 10.79 (-66.83%)	18.92M
CHSNChanson International Holding	$ 0.2268 (-58.76%)	5.89M
AIHSSenmiao Technology Ltd	$ 0.5921 (-42.51%)	11.19M
GNLNGreenlane Holdings Inc	$ 0.011099 (-27.93%)	252.34M
MULNMullen Automotive Inc	$ 2.335 (-27.71%)	1.65M
CGBSCrown LNG Holdings Ltd	$ 0.1378 (64.05%)	524.79M
HCTIHealthcare Triangle Inc	$ 0.0245 (-18.33%)	346.89M
GNLNGreenlane Holdings Inc	$ 0.011099 (-27.93%)	252.34M
USEGUS Energy Corp	$ 2.5088 (76.68%)	67.01M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.015 (-1.44%)	57.84M

Symbol

Price

Vol.

CGBSCrown LNG Holdings Ltd

$ 0.1378

(64.05%)

524.79M

HCTIHealthcare Triangle Inc

$ 0.0245

(-18.33%)

346.89M

GNLNGreenlane Holdings Inc

$ 0.011099

(-27.93%)

252.34M

USEGUS Energy Corp

$ 2.5088

(76.68%)

67.01M

TSLLDirexion Daily TSLA Bull 2X Trust ETF

$ 12.015

(-1.44%)

57.84M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Relay Therapeutics Inc (RLAY) Quote

Relay Therapeutics Inc (RLAY)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

About Relay Therapeutics Inc

Ask ADVFN Intelligence (AI)

RLAY Latest News

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

RLAY - Frequently Asked Questions (FAQ)

Movers

RLAY Discussion

Your Recent History

Company

Business

Popular

Get The App

Sign in

Go Ad-Free